cell line development Archives - Evercyte

Newly released telomerized endometrium-derived MSC April 1st, 2025, Vienna, AustriaWe are thrilled to announce the newest addition to our cell portfolio: Telomerized Endometrium-derived MSC!A

13 08, 2024

Newly released telomerized amniotic epithelial cells

Newly released telomerized amniotic epithelial cells

By Giulia Corso|2024-09-26T11:28:18+00:00August 13th, 2024|cell line development, recent highlights cell line development, telomerized cells|

Newly released telomerized amniotic epithelial cells August 13th, 2024, Vienna, Austria We are thrilled to announce the newest addition to our

27 06, 2024

Evercyte highlights immortalized cell technology at SelectBIO Rotterdam 2024

Evercyte highlights immortalized cell technology at SelectBIO Rotterdam 2024

By Giulia Corso|2024-09-26T11:28:45+00:00June 27th, 2024|cell line development, conferences, EV cell factories, extracellular vesicles, organ-on-a-chip|

Evercyte highlights immortalized cell technology at SelectBIO Rotterdam 2024 June 27th, 2024, Vienna, Austria We participated as technology spotlight speakers at

7 12, 2023

Evercyte contributing to reduce animal testing at key events

Evercyte contributing to reduce animal testing at key events

By Giulia Corso|2024-09-26T11:29:37+00:00December 7th, 2023|3Rs, cell line development, conferences, GCCP|

Evercyte contributing to reduce animal testing at key events December 7th, 2023, Vienna, Austria We participated as an invited attendee at

22 11, 2023

Evercyte Showcases Expertise in Japan’s Pharma Landscape

Evercyte Showcases Expertise in Japan’s Pharma Landscape

By Giulia Corso|2024-09-26T11:30:10+00:00November 22nd, 2023|cell line development, collaboration, EV cell factories, Extracellular Vesicles, mesenchymal stromal cells|

Evercyte Showcases Expertise in Japan’s Pharma Landscape November 22nd, 2023, Vienna, Austria We recently visited Summit Pharmaceuticals International to present our

Title